PANC -- Decent move yesterday which surprised me. I guess people thought there might be news with earnings. I did not expect any news, but maybe in the next few weeks. I posted PANC as a play over on 50% Gains when it was $4.00. Their drug works. The liquid form was fine, but the pill form failed to deliver the necessary does and down the stock went. I still think PANC will do good.
Below is a brief summary of their drug.
Have a great day. :-)
--------------------------------
HIV's resistance to drugs arises from its ability to quickly mutate. One mutation referred to by scientists as K103N, for instance, changes the shape of a ``pocket'' on the virus that some drugs were designed to hook into as they seek to disable the bug.
``Even under the best of circumstances, there will always be a gradual emergence of resistance,'' Fauci said. ``You're going to need a pipeline.''
Several companies have products on the horizon that may fulfill that need.
Panacos Experiment
Panacos Pharmaceuticals Inc., based in Watertown, Massachusetts, plans this year to begin the final phase of human testing needed for market clearance on its experimental drug, bevirimat. The drug is the only one in development to stop the virus in taking the final step it needs to become infectious, called ``maturation,'' according to Chief Operating Officer Graham Allaway.
``They can't spread the infection to new cells, and actually, they're cleared from the bloodstream,'' he says.
bloomberg.com |
